DISHMAN CARBOGEN AMCIS
Back to Cashflow Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-102 Cr | ₹-22 Cr | ₹250 Cr | ₹130 Cr | ₹-11 Cr |
What is the latest Cash Flow from Financing Activities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-102 Cr |
| Mar2024 | ₹-22 Cr |
| Mar2023 | ₹250 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹-11 Cr |
How is Cash Flow from Financing Activities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-102 Cr | Negative | |
| Mar2024 | ₹-22 Cr | Negative | |
| Mar2023 | ₹250 Cr | 91.52 | |
| Mar2022 | ₹130 Cr | Positive | |
| Mar2021 | ₹-11 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹3,099.9 Cr | -7.1% | 13% | -18.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.4% | 6.4% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -0.9% | 5% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 1.6% | 7.6% | 38.5% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.2% | 7.7% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.1% | -1.2% | 8.7% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -7.1% |
13% |
-18.1% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses